Improvements in Patient-Reported Outcomes Following Initiation of Dolutegravir-Based or Low-Dose Efavirenz-Based First-Line Antiretroviral Therapy: A Four-Year Longitudinal Analysis in Cameroon (NAMSAL ANRS 12313 Trial).

Marwân-Al-Qays BousmahCamelia ProtopopescuMireille Mpoudi-EtamePierrette Omgba BassegaGwenaëlle MaradanJustin OlingaMarie VarloteauxTamara Tovar-SanchezÉric DelaporteCharles KouanfackSylvie Boyernull null

Published in: Journal of acquired immune deficiency syndromes (1999) (2023)

ClinicalTrials.gov : NCT02777229.

Keyphrases

antiretroviral therapy
patient reported outcomes
hiv infected
hiv infected patients
low dose
human immunodeficiency virus
hiv positive
hiv aids
high dose
clinical trial
phase iii
study protocol
cross sectional
randomized controlled trial